| P50 | author | Camilo E Fadul | Q90247582 |
| P2093 | author name string | David Martin | |
| | Benjamin Purow | |
| | David Schiff | |
| | Haroon Ahmad | |
| | Sohil H Patel | |
| | Joseph Donahue | |
| | Beatriz Lopes | |
| P2860 | cites work | Delayed cerebral radiation necrosis | Q48182002 |
| | Late bilateral temporal lobe necrosis after conventional radiotherapy | Q48304219 |
| | Effect of bevacizumab on radiation necrosis of the brain | Q48304291 |
| | Significant response of radiation induced CNS toxicity to high dose steroid administration | Q48315083 |
| | Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma | Q48345995 |
| | Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery | Q48352674 |
| | Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma | Q48568497 |
| | Cerebral radiation necrosis following treatment of extracranial malignancies | Q48607087 |
| | A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. | Q48896456 |
| | Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. | Q51074035 |
| | Radiation damage to the brain--a new syndrome. | Q51285898 |
| | Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. | Q53883940 |
| | Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. | Q55114505 |
| | Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume | Q55490446 |
| | Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group stud | Q78020353 |
| | Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy | Q88043111 |
| | Treatment-Induced Brain Tissue Necrosis: A Clinical Challenge in Neuro-Oncology | Q92090880 |
| | CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. | Q30402063 |
| | Brain necrosis after permanent low-activity iodine-125 implants: case report and review of toxicity from focal radiation | Q30648926 |
| | Radiation therapy in the multimodal treatment approach of pituitary adenoma | Q30695617 |
| | The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence | Q30835167 |
| | A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. | Q31054271 |
| | Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial | Q33223508 |
| | Cerebral radionecrosis following the treatment of parotid tumours: a case report and review of the literature | Q33538312 |
| | Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma | Q34562175 |
| | IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas | Q35204658 |
| | The role of spirituality and religious coping in the quality of life of patients with advanced cancer receiving palliative radiation therapy | Q36082678 |
| | Radiation-induced cognitive impairment--from bench to bedside | Q36344693 |
| | Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours | Q38782122 |
| | Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy. | Q38814458 |
| | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 |
| | European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. | Q39291912 |
| | The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases | Q39811839 |
| | The Hazards of Therapeutic Irradiation of the Central Nervous System | Q40015689 |
| | Therapeutic irradiation and brain injury | Q40298944 |
| | Brain tumors: criteria of response and definition of recurrence | Q40892874 |
| | External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-45 Gy. | Q42486914 |
| | Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy | Q44653293 |
| | Molecular profiling optimizes the treatment of low-grade glioma | Q45047654 |
| | Leukoencephalopathy following combined therapy of central nervous system leukemia and lymphoma | Q45049331 |
| | MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients | Q46619783 |
| | Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases | Q46839934 |
| P433 | issue | 2 | |
| P921 | main subject | oligodendroglioma | Q1318384 |
| | adult oligodendroglioma | Q18555324 |
| P304 | page(s) | 309-319 | |
| P577 | publication date | 2019-09-23 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Oligodendroglioma confers higher risk of radiation necrosis | |
| P478 | volume | 145 | |